Darvocet-n 100 vs. Ambien: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Darvocet-n 100 and Ambien. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 183,070 people who take Darvocet-n 100 and Ambien, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
183,070 people who take Darvocet-n 100 and Ambien are studied.
What is Darvocet-n 100?
Darvocet-n 100 has active ingredients of acetaminophen; propoxyphene napsylate. It is often used in pain. eHealthMe is studying from 2,871 Darvocet-n 100 users for its effectiveness, alternative drugs and more.
What is Ambien?
Ambien has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 89,844 Ambien users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Ambien (zolpidem tartrate)
- Darvocet-N 100 (acetaminophen; propoxyphene napsylate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Darvocet-N 100:
- not at all: 2.79 %
- somewhat: 28.41 %
- moderate: 42.62 %
- high: 23.12 %
- very high: 3.06 %
Ambien:
- not at all: 2.07 %
- somewhat: 16.34 %
- moderate: 32.65 %
- high: 33.32 %
- very high: 15.61 %
Want to compare Darvocet-n 100 with Ambien?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Darvocet-n 100 (2,355 reports)
- Ambien (83,257 reports)
Common Darvocet-n 100 side effects:
- High blood pressure: 267 reports
- Chest pain: 263 reports
- Heart attack: 255 reports
- Breathing difficulty: 253 reports
- Stress and anxiety: 245 reports
- Weakness: 235 reports
- Fatigue (feeling of tiredness): 227 reports
- Dizziness: 206 reports
Browse all side effects of Darvocet-n 100:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Ambien side effects:
- Fatigue (feeling of tiredness): 7,733 reports
- Pain: 7,139 reports
- Stress and anxiety: 6,917 reports
- Insomnia (sleeplessness): 5,657 reports
- Headache (pain in head): 5,648 reports
Browse all side effects of Ambien:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on acetaminophen; propoxyphene napsylate and zolpidem tartrate (the active ingredients of Darvocet-n 100 and Ambien, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zinc Sulfate and Liver Transplant Rejection - 4 seconds ago
- Hair Loss and drugs of ingredients of ethinyl estradiol; norethindrone acetate - 16 seconds ago
- How effective is Darvocet-N 100 for Headache? - 17 seconds ago
- Urticaria Aggravated and Rash Maculo-Papular - 21 seconds ago
- Mobic and Hepatic Enzyme Increased - 21 seconds ago
- Amiodarone Hydrochloride and Drug Abuse And Dependence - 25 seconds ago
- Mobic and Hernia - 28 seconds ago
- How effective is Darvocet-N 100 for Back Pain? - 33 seconds ago
- Mobic and Stroke - 33 seconds ago
- Mobic and Cardiac Disorder - 41 seconds ago